Product category:
Chromatographs: gas
News Release from: Agilent Technologies Europe
Edited by the Laboratorytalk Editorial
Team on 07 August 2006
New vice president for life sciences
unit
Agilent Technologies has announced the appointment of Nick Roelofs as vice president and general manager of its life sciences solutions unit
This Agilent business unit serves basic research, disease research and pharmaceutical markets, which include genomics, proteomics, metabolomics, drug discovery/development and pharmaceutical quality control/quality assurance "Nick understands the needs of scientists and scientific organizations, and what it takes from a business standpoint to successfully serve these markets," said Chris van Ingen, president, Agilent Life Sciences and Chemical Analysis
This article was originally published on Laboratorytalk on 30 Jun 2008 at 8.00am (UK)
Related stories
Agilent updates CGH microarray software
For large-scale experiments, Agilent DNA Analytics 4.0 can process more than 100 microarrays (244K), helping users easily compare data and visualise patterns
"We're glad he decided to join Agilent".
Roelofs brings 19 years of life science and diagnostics experience to Agilent.
Previously, he was group operations officer of Bio-Rad Laboratories's Life Science Group.
He has also served as chief operating officer of Stratagene and has held senior positions at ABI and Baxter Diagnostic.
His doctorate in organic chemistry is from the University of Nevada, Reno, and he holds a master of science in organic chemistry from Iowa State University.
At Agilent, Roelofs is responsible for product profit and loss of the business group that includes microarrays, liquid chromatographs, microfluidics, mass spectrometers used in life science, capillary electrophoresis and informatics.
• Agilent Technologies Europe: contact details and other news
• Email this article to a colleague
• Register for the free Laboratorytalk email newsletter
• Laboratorytalk Home Page
Search the Pro-Talk network of sites
